Arno Groenewoud

Chief Financial Officer

Professional Overview
Arno Groenewoud is an experienced finance executive with a proven track record of driving strategic growth and operational excellence. As the Chief Financial Officer at Idorsia Pharmaceuticals Ltd, he leverages his deep expertise in international tax management and global financial leadership to support the company's ambitious pharmaceutical development initiatives.

Experience Summary

Current Role
As the Chief Financial Officer at Idorsia Pharmaceuticals Ltd, Arno is responsible for overseeing the company's financial strategy, planning, and reporting. He plays a crucial role in ensuring the efficient allocation of resources and the successful execution of Idorsia's R&D and commercialization efforts. Arno has been instrumental in optimizing the company's financial structures and processes, contributing to its ongoing expansion and market success.

Career Progression
Prior to joining Idorsia, Arno held senior international tax management roles at PricewaterhouseCoopers, where he advised multinational clients on complex tax planning and compliance strategies. He has also served as the Global Head of Tax at Actelion, further strengthening his expertise in the pharmaceutical industry.

Arno's career has been marked by consistent growth and increasing levels of responsibility, reflecting his ability to deliver tangible results and drive organizational performance.

Academic Background
Arno holds a degree in Economics and Business Administration from a prestigious university, with a specialization in International Taxation. His academic background has provided him with a strong foundation in financial analysis, strategic decision-making, and global business management.

Areas of Expertise

• International tax management and optimization

• Financial planning, forecasting, and reporting

• Strategic financial leadership in the pharmaceutical industry

• Operational efficiency and process improvement

• Mergers, acquisitions, and post-integration integration

Professional Impact
Throughout his career, Arno has been instrumental in driving significant financial and operational improvements for his employers. At Idorsia, he has played a key role in securing funding, optimizing capital allocation, and enhancing the company's financial resilience, enabling it to invest in critical R&D initiatives and achieve tangible growth milestones.

Conclusion
Arno Groenewoud is a highly accomplished finance executive with a proven track record of success in the pharmaceutical industry. With his deep expertise in international tax management, financial strategy, and operational optimization, he is well-positioned to continue driving Idorsia's growth and contributing to its long-term success as a leading innovator in the global pharmaceutical landscape.